Triggering of dendritic cell apoptosis by xanthohumol

Molecular Nutrition and Food Research

Volumn 54, Issue SUPPL. 2, 2010, Pages

  Xuan, Nguyen Thi ^a   Shumilina, Ekaterina ^a   Gulbins, Erich ^b   Gu, Shuchen ^a   Götz, Friedrich ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Anticarcinogen; Caspases; DNA fragmentation; Phosphatidylserine; Survival

Indexed keywords

CASPASE; CERAMIDE; FLAVONOID; IMMUNOLOGIC FACTOR; LIPOCORTIN 5; PHOSPHATIDYLSERINE; PROPIOPHENONE DERIVATIVE; SPHINGOMYELIN PHOSPHODIESTERASE; XANTHOHUMOL;

ANIMAL; APOPTOSIS; ARTICLE; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; CELL CYCLE G0 PHASE; CELL MEMBRANE; CELL SURVIVAL; DENDRITIC CELL; DNA FRAGMENTATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; GENETICS; METABOLISM; MOUSE; MOUSE MUTANT; OSMOLARITY; SURFACE PROPERTY;

ANIMALS; ANNEXIN A5; APOPTOSIS; BONE MARROW CELLS; CASPASES; CELL MEMBRANE; CELL SURVIVAL; CELLS, CULTURED; CERAMIDES; DENDRITIC CELLS; DNA FRAGMENTATION; ENZYME ACTIVATION; FLAVONOIDS; G0 PHASE; IMMUNOLOGIC FACTORS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSMOLAR CONCENTRATION; PHOSPHATIDYLSERINES; PROPIOPHENONES; SPHINGOMYELIN PHOSPHODIESTERASE; SURFACE PROPERTIES;

MUS;

EID: 79251517404     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200900324     Document Type: Article

References (74)

1. Intelmann, D., Haseleu, G., Hofmann, T., LC-MS/MS quantitation of hop-derived bitter compounds in beer using the ECHO technique. J. Agric. Food Chem. 2009, 57, 1172-1182.
2. Keukeleire, J. D., Janssens, I., Heyerick, A., Ghekiere, G. et al., Relevance of organic farming and effect of climatological conditions on the formation of alpha-acids, beta-acids, desmethylxanthohumol, and xanthohumol in hop (Humulus lupulus L.). J. Agric. Food Chem. 2007, 55, 61-66.
3. Kodama, S., Yamamoto, A., Sato, A., Suzuki, K. et al., Enantioseparation of isoxanthohumol in beer by hydroxypropyl-gamma-cyclodextrin-modified micellar electrokinetic chromatography. J. Agric. Food Chem. 2007, 55, 6547-6552.
4. Cho, Y. C., Kim, H. J., Kim, Y. J., Lee, K. Y. et al., Differential anti-inflammatory pathway by xanthohumol in IFN-gamma and LPS-activated macrophages. Int. Immunopharmacol. 2008, 8, 567-573.
5. Guo, J., Nikolic, D., Chadwick, L. R., Pauli, G. F. et al., Identification of human hepatic cytochrome P450 enzymes involved in the metabolism of 8-prenylnaringenin and isoxanthohumol from hops (Humulus lupulus L.). Drug Metab. Dispos. 2006, 34, 1152-1159.
6. Nikolic, D., Li, Y., Chadwick, L. R., Pauli, G. F. et al., Metabolism of xanthohumol and isoxanthohumol, prenylated flavonoids from hops (Humulus lupulus L.), by human liver microsomes. J. Mass Spectrom. 2005, 40, 289-299.
7. Pang, Y., Nikolic, D., Zhu, D., Chadwick, L. R. et al., Binding of the hop (Humulus lupulus L.) chalcone xanthohumol to cytosolic proteins in Caco-2 intestinal epithelial cells. Mol. Nutr. Food Res. 2007, 51, 872-879.
8. Avula, B., Ganzera, M., Warnick, J. E., Feltenstein, M. W. et al., High-performance liquid chromatographic determination of xanthohumol in rat plasma, urine, and fecal samples. J. Chromatogr. Sci. 2004, 42, 378-382.
9. Nookandeh, A., Frank, N., Steiner, F., Ellinger, R. et al., Xanthohumol metabolites in faeces of rats. Phytochemistry 2004, 65, 561-570.
10. Yano, K., Masaoka, Y., Kataoka, M., Sakuma, S. et al., Mechanisms of membrane transport of poorly soluble drugs: Role of micelles in oral absorption processes. J. Pharm. Sci. 2010, 99, 1336-1345.
11. Colgate, E. C., Miranda, C. L., Stevens, J. F., Bray, T. M. et al., Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells. Cancer Lett. 2007, 246, 201-209.
12. Dell'Eva, R., Ambrosini, C., Vannini, N., Piaggio, G. et al., AKT/NF-kappaB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies. Cancer 2007, 110, 2007-2011.
13. Diller, R. A., Riepl, H. M., Rose, O., Frias, C. et al., Synthesis of demethylxanthohumol, a new potent apoptosis-inducing agent from hops. Chem. Biodivers. 2005, 2, 1331-1337.
14. Gerhauser, C., Alt, A., Heiss, E., Gamal-Eldeen, A. et al., Cancer chemopreventive activity of xanthohumol, a natural product derived from hop. Mol. Cancer Ther. 2002, 1, 959-969.
15. Gerhauser, C., Beer constituents as potential cancer chemopreventive agents. Eur. J. Cancer 2005, 41, 1941-1954.
16. Goto, K., Asai, T., Hara, S., Namatame, I. et al., Enhanced antitumor activity of xanthohumol, a diacylglycerol acyltransferase inhibitor, under hypoxia. Cancer Lett. 2005, 219, 215-222.
17. Guerreiro, S., Monteiro, R., Martins, M. J., Calhau, C. et al., Distinct modulation of alkaline phosphatase isoenzymes by 17beta-estradiol and xanthohumol in breast cancer MCF-7 cells. Clin. Biochem. 2007, 40, 268-273.
18. Harikumar, K. B., Kunnumakkara, A. B., Ahn, K. S., Anand, P. et al., Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells. Blood 2009, 113, 2003-2013.
19. Ho, Y. C., Liu, C. H., Chen, C. N., Duan, K. J. et al., Inhibitory effects of xanthohumol from hops (Humulus lupulus L.) on human hepatocellular carcinoma cell lines. Phytother. Res. 2008, 22, 1465-1468.
20. Larghero, P., Vene, R., Minghelli, S., Travaini, G. et al., Biological assays and genomic analysis reveal lipoic acid modulation of endothelial cell behavior and gene expression. Carcinogenesis 2007, 28, 1008-1020.
21. Lust, S., Vanhoecke, B., Janssens, A., Philippe, J. et al., Xanthohumol kills B-chronic lymphocytic leukemia cells by an apoptotic mechanism. Mol. Nutr. Food Res. 2005, 49, 844-850.
22. Monteghirfo, S., Tosetti, F., Ambrosini, C., Stigliani, S. et al., Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-kappaB and p53 modulation. Mol. Cancer Ther. 2008, 7, 2692-2702.
23. Monteiro, R., Faria, A., Azevedo, I., Calhau, C., Modulation of breast cancer cell survival by aromatase inhibiting hop (Humulus lupulus L.) flavonoids. J. Steroid Biochem. Mol. Biol. 2007, 105, 124-130.
24. Monteiro, R., Calhau, C., Silva, A. O., Pinheiro-Silva, S. et al., Xanthohumol inhibits inflammatory factor production and angiogenesis in breast cancer xenografts. J. Cell Biochem. 2008, 104, 1699-1707.
25. Pan, L., Becker, H., Gerhauser, C., Xanthohumol induces apoptosis in cultured 40-16 human colon cancer cells by activation of the death receptor- and mitochondrial pathway. Mol. Nutr. Food Res. 2005, 49, 837-843.
26. Vanhoecke, B., Derycke, L., Van, M., V., Depypere, H. et al., Antiinvasive effect of xanthohumol, a prenylated chalcone present in hops (Humulus lupulus L.) and beer. Int. J Cancer 2005, 117, 889-895.
27. Choi, J. M., Kim, H. J., Lee, K. Y., Choi, H. J. et al., Increased IL-2 production in T cells by xanthohumol through enhanced NF-AT and AP-1 activity. Int. Immunopharmacol. 2009, 9, 103-107.
28. Wang, Q., Ding, Z. H., Liu, J. K., Zheng, Y. T., Xanthohumol, a novel anti-HIV-1 agent purified from Hops Humulus lupulus. Antiviral Res. 2004, 64, 189-194.
29. Gao, X., Deeb, D., Liu, Y., Gautam, S. et al., Immunomodulatory activity of xanthohumol: inhibition of T cell proliferation, cell-mediated cytotoxicity and Th1 cytokine production through suppression of NF-kappaB. Immunopharmacol. Immunotoxicol. 2009, 31, 477-484.
30. Zhao, F., Nozawa, H., Daikonnya, A., Kondo, K. et al., Inhibitors of nitric oxide production from hops (Humulus lupulus L.). Biol. Pharm. Bull. 2003, 26, 61-65.
31. Lee, J. A., Hwang, J. A., Sung, H. N., Jeon, C. H. et al., 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin modulates functional differentiation of mouse bone marrow-derived dendritic cells Downregulation of RelB by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Toxicol. Lett. 2007, 173, 31-40.
32. Dai, J., Patel, J. D., Mumper, R. J., Characterization of blackberry extract and its antiproliferative and anti-inflammatory properties. J. Med. Food 2007, 10, 258-265.
33. Dijsselbloem, N., Goriely, S., Albarani, V., Gerlo, S. et al., A critical role for p53 in the control of NF-kappaB-dependent gene expression in TLR4-stimulated dendritic cells exposed to Genistein. J. Immunol. 2007, 178, 5048-5057.
34. Kim, Y. J., Choi, S. E., Lee, M. W., Lee, C. S., Taxifolin glycoside inhibits dendritic cell responses stimulated by lipopolysaccharide and lipoteichoic acid. J. Pharm. Pharmacol. 2008, 60, 1465-1472.
35. Lee, J. S., Kim, S. G., Kim, H. K., Lee, T. H. et al., Silibinin polarizes Th1/Th2 immune responses through the inhibition of immunostimulatory function of dendritic cells. J. Cell Physiol 2007, 210, 385-397.
36. Li, C. Y., Suen, J. L., Chiang, B. L., Lee Chao, P. D. et al., Morin promotes the production of Th2 cytokine by modulating bone marrow-derived dendritic cells. Am. J. Chin Med. 2006, 34, 667-684.
37. Yoneyama, S., Kawai, K., Tsuno, N. H., Okaji, Y. et al., Epigallocatechin gallate affects human dendritic cell differentiation and maturation. J. Allergy Clin. Immunol. 2008, 121, 209-214.
38. Kang, H. K., Ecklund, D., Liu, M., Datta, S. K., Apigenin, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells. Arthritis Res. Ther. 2009, 11, R59.
39. Adler, H. S., Steinbrink, K., Tolerogenic dendritic cells in health and disease: friend and foe! Eur. J. Dermatol. 2007, 17, 476-491.
40. Banchereau, J., Briere, F., Caux, C., Davoust, J. et al., Immunobiology of dendritic cells. Annu. Rev. Immunol 2000, 18, 767-811.
41. van Duivenvoorde, L. M., Han, W. G., Bakker, A. M., Louis-Plence, P. et al., Immunomodulatory dendritic cells inhibit Th1 responses and arthritis via different mechanisms. J. Immunol. 2007, 179, 1506-1515.
42. Cerovic, V., McDonald, V., Nassar, M. A., Paulin, S. M. et al., New insights into the roles of dendritic cells in intestinal immunity and tolerance. Int. Rev. Cell Mol. Biol 2009, 272, 33-105.
43. Edelman, S. M., Kasper, D. L., Symbiotic commensal bacteria direct maturation of the host immune system. Curr. Opin Gastroenterol. 2008, 24, 720-724.
44. Silva, M. A., Intestinal dendritic cells and epithelial barrier dysfunction in Crohn's disease. Inflamm. Bowel Dis. 2009, 15, 436-453.
45. Horinouchi, K., Erlich, S., Perl, D. P., Ferlinz, K. et al., Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat. Genet. 1995, 10, 288-293.
46. Lin, T., Genestier, L., Pinkoski, M. J., Castro, A. et al., Role of acidic sphingomyelinase in Fas/CD95-mediated cell death. J. Biol. Chem. 2000, 275, 8657-8663.
47. Inaba, K., Inaba, M., Romani, N., Aya, H. et al., Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992, 176, 1693-1702.
48. Matzner, N., Zemtsova, I. M., Nguyen, T. X., Duszenko, M. et al., Ion channels modulating mouse dendritic cell functions. J. Immunol. 2008, 181, 6803-6809.
49. Shumilina, E., Zahir, N., Xuan, N. T., Lang, F., Phosphoinositide 3-kinase dependent regulation of Kv channels in dendritic cells. Cell Physiol. Biochem. 2007, 20, 801-808.
50. Grassme, H., Jendrossek, V., Riehle, A., von Kurthy, G. et al., Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat. Med. 2003, 9, 322-330.
51. Wang, K., Mahmud, H., Foller, M., Biswas, R. et al., Lipopeptides in the triggering of erythrocyte cell membrane scrambling. Cell Physiol. Biochem. 2008, 22, 381-386.
52. Grassme, H., Schwarz, H., Gulbins, E., Molecular mechanisms of ceramide-mediated CD95 clustering. Biochem. Biophys. Res. Commun. 2001, 284, 1016-1030.
53. Gulbins, E., Li, P. L., Physiological and pathophysiological aspects of ceramide. Am. J. Physiol. Regul. Integr. Comp Physiol 2006, 290, R11-R26.
54. Wang, E., Norred, W. P., Bacon, C. W., Riley, R. T. et al., Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J. Biol. Chem. 1991, 266, 14486-14490.
55. Yang, J. Y., Della-Fera, M. A., Rayalam, S., Baile, C. A., Effect of xanthohumol and isoxanthohumol on 3T3-L1 cell apoptosis and adipogenesis. Apoptosis 2007, 12, 1953-1963.
56. Yang, J. Y., Della-Fera, M. A., Rayalam, S., Baile, C. A., Enhanced effects of xanthohumol plus honokiol on apoptosis in 3T3-L1 adipocytes. Obesity. (Silver Spring) 2008, 16, 1232-1238.
57. Mendes, V., Monteiro, R., Pestana, D., Teixeira, D. et al., Xanthohumol influences preadipocyte differentiation: implication of antiproliferative and apoptotic effects. J. Agric. Food Chem. 2008, 56, 11631-11637.
58. Albini, A., Pfeffer, U., A new tumor suppressor gene: invasion, metastasis, and angiogenesis as potential key targets. J. Natl. Cancer Inst. 2006, 98, 800-801.
59. Vogel, S., Heilmann, J., Synthesis, cytotoxicity, and antioxidative activity of minor prenylated chalcones from Humulus lupulus. J. Nat. Prod. 2008, 71, 1237-1241.
60. Dietz, B. M., Kang, Y. H., Liu, G., Eggler, A. L. et al., Xanthohumol isolated from Humulus lupulus Inhibits menadione-induced DNA damage through induction of quinone reductase. Chem. Res. Toxicol. 2005, 18, 1296-1305.
61. Carpinteiro, A., Dumitru, C., Schenck, M., Gulbins, E., Ceramide-induced cell death in malignant cells. Cancer Lett. 2008, 264, 1-10.
62. Grassme, H., Becker, K. A., Zhang, Y., Gulbins, E., Ceramide in bacterial infections and cystic fibrosis. Biol. Chem. 2008, 389, 1371-1379.
63. Jana, A., Hogan, E. L., Pahan, K., Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death. J. Neurol. Sci. 2009, 278, 5-15.
64. Lang, F., Gulbins, E., Lerche, H., Huber, S. M. et al., Eryptosis, a window to systemic disease. Cell Physiol. Biochem. 2008, 22, 373-380.
65. Perrotta, C., De Palma, C., Clementi, E., Nitric oxide and sphingolipids: mechanisms of interaction and role in cellular pathophysiology. Biol. Chem. 2008, 389, 1391-1397.
66. Smith, E. L., Schuchman, E. H., The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases. FASEB J. 2008, 22, 3419-3431.
67. Quadri, S. M., Mahmud, H., Föller, M., Lang, F., Inhibition of suicidal erythrocyte death by xanthohumol. J. Agric. Food Chem. 2010, In press.
68. Brand, V., Koka, S., Lang, C., Jendrossek, V. et al., Influence of amitriptyline on eryptosis, parasitemia and survival of Plasmodium berghei-infected mice. Cell Physiol. Biochem. 2008, 22, 405-412.
69. Sopjani, M., Foller, M., Dreischer, P., Lang, F., Stimulation of eryptosis by cadmium ions. Cell Physiol. Biochem. 2008, 22, 245-252.
70. Sopjani, M., Foller, M., Gulbins, E., Lang, F., Suicidal death of erythrocytes due to selenium-compounds. Cell Physiol. Biochem. 2008, 22, 387-394.
71. Albini, A., Dell'Eva, R., Vene, R., Ferrari, N. et al., Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets. FASEB J. 2006, 20, 527-529.
72. Vanhoecke, B. W., Delporte, F., Van Braeckel, E., Heyerick, A. et al., A safety study of oral tangeretin and xanthohumol administration to laboratory mice. In Vivo 2005, 19, 103-107.
73. Lundqvist, A., Nagata, T., Kiessling, R., Pisa, P., Mature dendritic cells are protected from Fas/CD95-mediated apoptosis by upregulation of Bcl-X(L). Cancer Immunol. Immunother. 2002, 51, 139-144.
74. Leverkus, M., Walczak, H., McLellan, A., Fries, H. W. et al., Maturation of dendritic cells leads to up-regulation of cellular FLICE-inhibitory protein and concomitant down-regulation of death ligand-mediated apoptosis. Blood 2000, 96, 2628-2631.